REQUEST A DEMO
Total
USD $0.00
Search more companies

Pet Pharm Biotech Co. Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pet Pharm Biotech Co. Ltd. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Pet Pharm Biotech Co. Ltd. is a company based in Taiwan, China, with its head office in New Taipei City. It operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on April 12, 2026. It currently has a total number of 45 (2024) employees. From the latest financial highlights, Pet Pharm Biotech Co. Ltd. reported a net sales revenue increase of 50.64% in Q2C2025. Its’ total assets recorded a growth of 66.8%. The enterprise’s net profit margin increased by 3.6% in 2025.

Headquarters
1-2F., No. 141,143, Hougang 1St Rd Xinzhuang Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the Pet Pharm Biotech Co. Ltd. report to view the information.

Website: http://www.petpharmbio.com

Basic Information
Total Employees:
Purchase the Pet Pharm Biotech Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the Pet Pharm Biotech Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Pet Pharm Biotech Co. Ltd. report to view the information.
Incorporation Date:
April 12, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
6.89%
Purchase this report to view the information.
3.36%
Purchase this report to view the information.
3.34%
Purchase this report to view the information.
2.77%
Purchase this report to view the information.
2.1%
Company Performance
Financial values in the chart are available after Pet Pharm Biotech Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
50.64%
Total Operating Revenue
50.64%
Operating Profit
105.85%
EBITDA
42.12%
Net Profit/Loss for the Period
141.01%
Total Assets
66.8%
Total Equity
83.65%
Operating Profit Margin
0.98%
Net Profit Margin
3.6%
Return on Equity (ROE)
0.22%
Debt / Equity
-10491%
Quick Ratio
1718.68%
Cash Ratio
1.32%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?